KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adient (ADNT) Asset Writedowns and Impairment (2016 - 2025)

Adient (ADNT) has disclosed Asset Writedowns and Impairment for 8 consecutive years, with -$2.0 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Asset Writedowns and Impairment fell 122.22% year-over-year to -$2.0 million, compared with a TTM value of $331.0 million through Dec 2025, up 1642.11%, and an annual FY2025 reading of $341.0 million, up 3688.89% over the prior year.
  • Asset Writedowns and Impairment was -$2.0 million for Q3 2025 at Adient, down from $333.0 million in the prior quarter.
  • Across five years, Asset Writedowns and Impairment topped out at $333.0 million in Q1 2025 and bottomed at -$8.0 million in Q3 2022.
  • Average Asset Writedowns and Impairment over 4 years is $32.3 million, with a median of $2.0 million recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment soared 101.73% in 2021, then crashed 300.0% in 2022.
  • Year by year, Asset Writedowns and Impairment stood at $7.0 million in 2021, then crashed by 214.29% to -$8.0 million in 2022, then soared by 225.0% to $10.0 million in 2024, then tumbled by 120.0% to -$2.0 million in 2025.
  • Business Quant data shows Asset Writedowns and Impairment for ADNT at -$2.0 million in Q3 2025, $333.0 million in Q1 2025, and $10.0 million in Q4 2024.